Unaudited Consolidated Statements of Cash Flows - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Feb. 25, 2023	Feb. 26, 2022	Feb. 25, 2023	Feb. 26, 2022
Operating activities:
Net income	$ 6,340	$ 2,887	$ 18,213	$ 9,644
Adjustments to reconcile net income to cash used in operating activities:
Depreciation and amortization	912	872	2,688	2,560
Inventory provisions	115	88	310	228
Share-based compensation expense	206	142	730	514
Loss (gain) on disposal of assets	13	0	(12)	2
Deferred income taxes	(1)	26	27	38
Change in assets and liabilities:
Accounts receivable	(7,189)	(4,209)	(12,694)	(7,355)
Inventories	(3,638)	(3,113)	(21,764)	(12,295)
Prepaid expenses and other assets	(153)	(2)	(578)	(1,058)
Accounts payable	(12)	1,902	784	4,204
Accrued liabilities	(661)	563	486	2,075
Other	(192)	(370)	397	(13)
Net cash used in operating activities	(4,260)	(1,214)	(11,413)	(1,456)
Investing activities:
Capital expenditures	(2,230)	(554)	(4,973)	(2,161)
Proceeds from maturity of investments	5,000	0	5,000	0
Proceeds from sale of assets	0	0	193	0
Net cash provided by (used in) investing activities	2,770	(554)	220	(2,161)
Financing activities:
Proceeds from issuance of common stock	511	1,906	3,413	2,630
Cash dividends paid	(834)	(806)	(2,484)	(2,384)
Other	0	(45)	(69)	(136)
Net cash (used in) provided by financing activities	(323)	1,055	860	110
Effect of exchange rate changes on cash and cash equivalents	352	195	(517)	(662)
Decrease in cash and cash equivalents	(1,461)	(518)	(10,850)	(4,169)
Cash and cash equivalents at beginning of period	26,106	39,665	35,495	43,316
Cash and cash equivalents at end of period	$ 24,645	$ 39,147	$ 24,645	$ 39,147